Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03331393 · ClinicalTrials.gov registry record

The Value of Orencia in Rapidly Progressing Rheumatoid Arthritis

A clinical trial of Rheumatoid Arthritis, sponsored by Bristol-Myers Squibb.

Completed
Registry status
265
Enrollment target
7
Study locations

NCT03331393 is a study of Rheumatoid Arthritis that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 265 participants, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (94% lower). The trial reports 7 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03331393, a study of Rheumatoid Arthritis, has completed, sponsored by Bristol-Myers Squibb.

COMPLETED
Registry status
265 participants
Enrollment target
7
Study locations

Study Summary

The purpose of this study is to investigate the value of Orencia in rapidly progressing Rheumatoid Arthritis (RA).

Conditions Studied

Rheumatoid Arthritis

Interventions

  • OTHER Non-interventional

Study Locations (7)

California

  • Local Institution - Beverly Hills

Georgia

  • Local Institution - 0005 - Gainesville

Idaho

  • Local Institution - Coeur d'Alene

Minnesota

  • Local Institution - 0007 - Eagan

North Carolina

  • Medication Management, LLC - Greensboro

South Carolina

  • Local Institution - Myrtle Beach

Washington

  • Local Institution - Richland

Trial Details

FieldValue
Enrollment Target 265 participants
Start Date 2017-03-16
Est. Completion 2019-01-17

Sponsor

Bristol-Myers Squibb

1,025 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03331393

The ClinicalTrials.gov registry entry for NCT03331393 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 265 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (94% lower). The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Non-interventional is the first listed.

NCT03331393 reports 7 study locations spanning 7 distinct geographic areas - top geographies include California, Georgia, Idaho.

Frequently Asked Questions

What is clinical trial NCT03331393 about?

NCT03331393 is a clinical study titled "The Value of Orencia in Rapidly Progressing Rheumatoid Arthritis". The purpose of this study is to investigate the value of Orencia in rapidly progressing Rheumatoid Arthritis (RA).

What is the current status of trial NCT03331393?

This trial is currently completed. The enrollment target is 265 participants. The study started on 2017-03-16. Estimated completion is 2019-01-17.

What conditions does trial NCT03331393 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis.

What interventions are being tested in trial NCT03331393?

The interventions under investigation include: Non-interventional (OTHER).

Who is sponsoring clinical trial NCT03331393?

This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03331393 being conducted?

This trial has 7 study locations across California, Georgia, Idaho, Minnesota, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Rheumatoid Arthritis

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.